May 10, 2007 - The U.S. Senate approved legislation on Wednesday to give the government new powers to police side effects of prescription drugs.

The measure responds to the 2004 withdrawal of the arthritis pill
Vioxx and complaints that regulators did not respond quickly to early signs of heart problems with the Merck & Co Inc. drug.

The bill is meant to strengthen FDA oversight after a drug is approved. The measure also extends industry fees that help pay for product reviews.

The Senate measure must be reconciled with legislation expected in the House of Representatives.


Additional Content

News | Enterprise Imaging

June 28, 2024 — Konica Minolta Healthcare Americas announced today a strategic partnership with Apollo Enterprise ...

Time June 28, 2024
arrow
News | Radiology Imaging

May 31, 2024 — MDView, a virtual care and medical second opinion platform, surveys users of its Radiology Second Opinion ...

Time May 31, 2024
arrow
Feature | Digital Radiography (DR) | By Melinda Taschetta-Millane

Digital radiography (DR) continues to advance at a rapid pace with today’s technological innovations and evolving ...

Time May 06, 2024
arrow
Feature | Information Technology | By Jef Williams

The rapid growth of healthcare data has reached unprecedented heights, making up about 30% of the world’s stored data.¹ ...

Time April 30, 2024
arrow
News | Cybersecurity

March 14, 2024 — The American Medical Association (AMA) has issued a new letter to federal officials in which it praised ...

Time March 14, 2024
arrow
Subscribe Now